KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Non-Current Debt (2018 - 2021)

Historic Non-Current Debt for TherapeuticsMD (TXMD) over the last 6 years, with Q3 2021 value amounting to $171.7 million.

  • TherapeuticsMD's Non-Current Debt fell 2755.24% to $171.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $171.7 million, marking a year-over-year decrease of 2755.24%. This contributed to the annual value of $237.7 million for FY2020, which is 2212.52% up from last year.
  • TherapeuticsMD's Non-Current Debt amounted to $171.7 million in Q3 2021, which was down 2755.24% from $175.3 million recorded in Q2 2021.
  • In the past 5 years, TherapeuticsMD's Non-Current Debt registered a high of $243.4 million during Q1 2020, and its lowest value of $73.1 million during Q2 2018.
  • Moreover, its 4-year median value for Non-Current Debt was $179.0 million (2021), whereas its average is $163.1 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first surged by 23119.02% in 2020, then tumbled by 2755.24% in 2021.
  • Quarter analysis of 4 years shows TherapeuticsMD's Non-Current Debt stood at $73.4 million in 2018, then surged by 165.24% to $194.6 million in 2019, then increased by 22.13% to $237.7 million in 2020, then dropped by 27.75% to $171.7 million in 2021.
  • Its Non-Current Debt was $171.7 million in Q3 2021, compared to $175.3 million in Q2 2021 and $179.0 million in Q1 2021.